Evidence map›Paper›PMID 36369420›Full record

Observational studyJournal of thrombosis and thrombolysis2023

Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention.

Ioannis Lianos, Charalampos Varlamos, Despoina-Rafailia Benetou, Christos Mantis, Konstantinos Kintis, Vassiliki-Maria Dragona, Ioannis Kanakakis, Dimitrios Sionis, Sotirios Patsilinakos, Dimitrios Alexopoulos

Open access · hybridAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Journal of thrombosis and thrombolysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ioannis Lianos2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece.
Charalampos Varlamos2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece.
Despoina-Rafailia Benetou2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece.
Christos MantisDepartment of Cardiology, Konstantopoulion Hospital, Athens, Greece.
Konstantinos KintisDepartment of Cardiology, Konstantopoulion Hospital, Athens, Greece.
Vassiliki-Maria Dragona3rd Department of Internal Medicine, Red Cross Hospital, Athens, Greece.
Ioannis KanakakisDepartment of Clinical Therapeutics, "Alexandra" University Hospital, Athens, Greece.
Dimitrios SionisDepartment of Cardiology, Sismanoglion Hospital, Athens, Greece.
Sotirios PatsilinakosDepartment of Cardiology, Konstantopoulion Hospital, Athens, Greece.
Dimitrios Alexopoulos2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece. dalex@med.uoa.gr.
National and Kapodistrian University of Athens · GRAgia Olga Hospital · GRAlexandra Hospital · GRHellenic Red Cross · GRSismanoglio General Hospital · GR

Funding

Hellenic Cardiac Society N/A
6 · The paper itself

Abstract

Platelet function testing (PFT) could be a useful clinical tool to guide individualized antithrombotic treatment in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI). We aimed to investigate platelet reactivity (PR) in the context of a contemporary registry. "Real-world" data were retrieved from a nationwide, multicenter, observational study of AF patients on oral anticoagulants (OAC) undergoing PCI. Patients treated with a P2Y

Indexed as

Atrial FibrillationPercutaneous Coronary InterventionAnticoagulantsClopidogrelFibrinolytic AgentsHumansPlatelet Aggregation InhibitorsTicagrelorTreatment OutcomeAnticoagulantsClopidogrelFibrinolytic AgentsPlatelet Aggregation InhibitorsTicagrelorAtrial fibrillationDouble antithrombotic therapyP2Y12 inhibitorPercutaneous coronary interventionPlatelet function

Identifiers

PMID36369420
PMCPMC9925488
OpenAlexW4308834636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.